GraniteShares 3x Short AstraZeneca Daily ETC (3SAZ) 4.658 GBP (+2.10%) | Healthcare & Biotech London Stock Exchange

Listed product offering daily inverse triple exposure to AstraZeneca plc shares.

Observed momentum is extremely weak and confirms a persistently adverse trend for this type of instrument. The strategic takeaway is clear: the product has suffered from a structural bias linked to its leveraged inverse mechanism, and it should be considered a one-off trading tool rather than a buy-and-hold position.

GraniteShares 3x Short AstraZeneca Daily ETC

Trend Analysis of GraniteShares 3x Short AstraZeneca Daily ETC

Want to see the full analysis?